It has been previously found that GH replacement therapy had favorable effects on separate components of the metabolic syndrome, apart from a possible deterioration of insulin sensitivity and glycemic control, particularly in patients with elevated body mass index [93,94,95,96]. The gene discussed is GH1; the disease is metabolic syndrome.